πŸ‡ΊπŸ‡Έ FDA
Patent

US 8404852

Gyrase inhibitors and uses thereof

granted A61KA61K31/4439A61K31/506

Quick answer

US patent 8404852 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4439, A61K31/506, A61P, A61P31/04